News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

$5.6 Billion Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Buyout Deal Means High Drug Prices For All


4/8/2014 6:49:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

If you’re starting a biotechnology company and thinking of developing anything other than a super-high-priced medicine for a niche market, this morning’s news that Questcor Pharmaceuticals is being bought by Dublin-based specialty pharma Mallinckrodt for $5.6 billion may make you reconsider. Forget new drugs for any common diseases, find an old one that you can justify charging a lot more for.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes


comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES